Does met-CCL5 represent an immunotherapy strategy to ameliorate rabies virus infection?
These results suggest that CCL5 in the CNS is a key regulator involved in inducing rabies encephalomyelitis. Furthermore, treatment with the CCL5 antagonist Met-CCL5 prolongs survival time of the mice infected with attenuated or street RABVs, which might represent a novel therapeutic strategy to ameliorate RABV infection.
Small sample sizes appear to drive the Negative Group's finding that leg length is not statistically significantly related to early life conditions. However, the magnitude of the relationship confirms the Negative Group's argument that leg length is not a more accurate biomarker of early life conditions than height.